Middle East & Africa Neurovascular Devices Market Size & Outlook

The neurovascular devices market in Middle East & Africa is expected to reach a projected revenue of US$ 590.6 million by 2030. A compound annual growth rate of 6.1% is expected of Middle East & Africa neurovascular devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$389.3
Forecast, 2030 (US$M)
$590.6
CAGR, 2024 - 2030
6.1%
Report Coverage
Middle East & Africa

MEA neurovascular devices market highlights

  • The MEA neurovascular devices market generated a revenue of USD 389.3 million in 2023.
  • The market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
  • Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.
  • Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 389.3 million
Market revenue in 2030USD 590.6 million
Growth rate6.1% (CAGR from 2023 to 2030)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentSupport Devices
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp


Other key industry trends

  • In terms of revenue, MEA region accounted for 12.9% of the global neurovascular devices market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,092.8 million by 2030.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 35.22% in 2023. Horizon Databook has segmented the Middle East & Africa neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.


The neurovascular devices market in MEA region is anticipated to witness moderate growth over the forecast period. Middle Eastern countries such as Saudi Arabia, South Africa, and the UAE are some of the prospering economies. 

Increasing healthcare expenditure and gradual adoption of technologically advanced products in these countries are among factors expected to promote market growth.

In addition, increasing incidence of acute ischemic stroke in South Africa, Saudi Arabia, and the UAE is expected to propel the market growth. However, lack of skilled professionals and advanced healthcare settings may hinder the market growth over the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website

MEA neurovascular devices market size, by country, 2018-2030 (US$M)

Middle East & Africa Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)

MEA neurovascular devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more